  See all
 |
Articles: Drug Approvals |
Prior Articles
FDA Issues Complete Response Letter for Corvue
King Pharmaceuticals, 10/22/09
Free full text
Shire Targets Fourth Quarter Filing of BLA for REPLAGAL? for Fabry Disease with U.S. FDA
Shire, 10/22/09 FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09 CEL-SCI To Commence First Clinical Study With Hospitalized H1N1 Infected Patients
CEL-SCI, 10/21/09 FDA approves Micardis as the first treatment in its class to reduce the risk of heart attack, stroke, or death from cardiovascular causes in patients at high cardiovascular risk who are unable to take ACE inhibitors
Boehringer Ingelheim, 10/20/09
Free full text
FDA approves Twynsta a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours
Boehringer Ingelheim, 10/20/09
Free full text
Novartis receives Complete Response letter from FDA for QAB149, an investigational bronchodilator for COPD
Novartis, 10/20/09
Free full text
Angiotech Pharmaceuticals Provides Update on Bio-Seal™ 510(K) Submission
Angiotech Pharmaceuticals, 10/20/09
Free full text
Amgen Provides Update on Status of Prolia Biologics License Application Submitted to the U.S. Food and Drug Administration
Amgen, 10/20/09
Free full text
Dexlansoprazole MR
Expert Opinion in Pharmacotherapy, 10/19/09 FDA Approves GARDASIL for Use in Boys and Young Men
Merck & Co., 10/19/09
Free full text
U.S. Food and Drug Administration approves CRESTOR for use in pediatric patients with heterozygous familial hypercholesterolemia
AstraZeneca, 10/19/09
Free full text
GSKs Cervarix becomes the first cervical cancer vaccine to gain approval in Japan
GlaxoSmithKline, 10/19/09
Free full text
Anti-Malignancy Agent/Anti-VEGF Humanized Monoclonal Antibody, Avastin Application for Approval of Additional Indication of Breast Cancer
Chugai Pharmaceutical Co., 10/19/09
Free full text
Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
Journal of Clinical Oncology, 10/16/09 Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
Pharmaceutical Technology, 10/14/09
Free full text
Two different approaches for the prediction of In Vivo plasma concentration-time profile from In Vitro release data of once daily formulations of diltiazem hydrochloride
Archives of Pharmacal Research, 10/14/09
Free full text
Novartis enters into agreement for exclusive US and Canadian rights to Fanapt(TM), an FDA-approved oral therapy for schizophrenia
Novartis, 10/13/09
Free full text
Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization
Expert Review of Anti-infective Therapy, 10/09/09 APP Pharmaceuticals Receives Approval for Sumatriptan Succinate Injection, USP
American Pharmaceutical Partners, 10/09/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
168 Available Pages
|
|
